New ointment aims to heal bedsores faster in diabetic patients
NCT ID NCT05199077
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests an ointment called GM-XANTHO for treating stage II or III pressure ulcers (bedsores) in people with diabetes. About 58 participants will receive either a low or high dose of the ointment or a placebo, along with standard care. The goal is to see if the ointment helps ulcers heal faster and safely.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- GM-XANTHO ointment
- What this could lead to
- If successful, this could provide a new topical treatment to help heal pressure ulcers faster and reduce complications.
- What could go wrong
- This is an early Phase IIa study with only 58 participants, so results may not apply to everyone. The ointment may not work better than standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Taiwan University Hospital
Taipei, Taipei, 100225, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- FitBit coaching may help amputees walk more after surgery
- Can AI catch the leading cause of blindness before It's too late?
- Does feeling stigmatized worsen life quality for men with low testosterone?
- Can community hospitals in zambia master severe disease care?
- Can a wearable sensor beat Finger-Prick tests for type 2 diabetes?
- Brain training may sharpen aging minds in diabetes